[1]
N. Yahcoob, B. Lakshmanan, J. Achuthanandhan, and V. Balakrishnan, “In-silico screening of 2,3-diphenylquinozaline derivatives as C-met kinase inhibitors”, J Pharm Chem, vol. 4, no. 3, pp. 41–45, Nov. 2021, doi: 10.14805/jphchem.2017.art84.